Antisense ATM gene therapy: a strategy to increase the radiosensitivity of human tumors
暂无分享,去创建一个
B. Vikram | T. Pandita | W. Mellado | C. Guha | U. Guha | S. Tribius | A. Alfieri | D. Casper | P. Chakravarty
[1] J. Pontén,et al. Long term culture of normal and neoplastic human glia. , 2009, Acta pathologica et microbiologica Scandinavica.
[2] E. Gosink,et al. Ataxia telangiectasia mutated deficiency affects astrocyte growth but not radiosensitivity. , 1999, Cancer research.
[3] P. Leder,et al. Loss of atm radiosensitizes multiple p53 null tissues. , 1998, Cancer research.
[4] Y Taya,et al. Activation of the ATM kinase by ionizing radiation and phosphorylation of p53. , 1998, Science.
[5] T. Jacks,et al. Involvement of p53 and p21 in Cellular Defects and Tumorigenesis in Atm−/− Mice , 1998, Molecular and Cellular Biology.
[6] E. Stavridi,et al. ATM-dependent activation of p53 involves dephosphorylation and association with 14-3-3 proteins , 1998, Nature Genetics.
[7] J. Morgan,et al. Requirement for Atm in ionizing radiation-induced cell death in the developing central nervous system. , 1998, Science.
[8] C. Deng,et al. Atm selectively regulates distinct p53-dependent cell-cycle checkpoint and apoptotic pathways , 1997, Nature Genetics.
[9] Y. Shiloh,et al. Fragments of ATM which have dominant-negative or complementing activity , 1997, Molecular and cellular biology.
[10] A. Levine. p53, the Cellular Gatekeeper for Growth and Division , 1997, Cell.
[11] D. Baltimore,et al. Dual roles of ATM in the cellular response to radiation and in cell growth control. , 1996, Genes & development.
[12] Francis Collins,et al. Atm-Deficient Mice: A Paradigm of Ataxia Telangiectasia , 1996, Cell.
[13] W. Dewey,et al. Cell cycle synchrony unmasks the influence of p53 function on radiosensitivity of human glioblastoma cells. , 1996, Cancer research.
[14] K. Khanna,et al. Nature of G1/S cell cycle checkpoint defect in ataxia-telangiectasia. , 1995, Oncogene.
[15] Samuel Hellman,et al. Spatial and temporal control of gene therapy using ionizing radiation , 1995, Nature Medicine.
[16] M. Lovett,et al. A single ataxia telangiectasia gene with a product similar to PI-3 kinase. , 1995, Science.
[17] S. Kim,et al. Selective enhancement by an antiviral agent of the radiation-induced cell killing of human glioma cells transduced with HSV-tk gene. , 1994, Cancer research.
[18] S. A. Roberts,et al. Intrinsic radiosensitivity and prediction of patient response to radiotherapy for carcinoma of the cervix. , 1993, British Journal of Cancer.
[19] E. Jaffee,et al. Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[20] B. Vogelstein,et al. A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia-telangiectasia , 1992, Cell.
[21] M. Kastan,et al. Wild-type p53 is a cell cycle checkpoint determinant following irradiation. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[22] B. Vogelstein,et al. Participation of p53 protein in the cellular response to DNA damage. , 1991, Cancer research.
[23] H. Vinters,et al. Ataxia‐Telangiectasia: An Interdisciplinary Approach to Pathogenesis , 1991, Medicine.
[24] R. Painter,et al. Radiosensitivity in ataxia-telangiectasia: a new explanation. , 1980, Proceedings of the National Academy of Sciences of the United States of America.
[25] A. Taylor,et al. Ataxia telangiectasia: a human mutation with abnormal radiation sensitivity , 1975, Nature.
[26] Y Taya,et al. Enhanced phosphorylation of p53 by ATM in response to DNA damage. , 1998, Science.
[27] S. Kim,et al. Glioma cells transduced with an Escherichia coli CD/HSV-1 TK fusion gene exhibit enhanced metabolic suicide and radiosensitivity. , 1997, Human gene therapy.
[28] S. A. Roberts,et al. The independence of intrinsic radiosensitivity as a prognostic factor for patient response to radiotherapy of carcinoma of the cervix. , 1997, British Journal of Cancer.
[29] W. Dewey,et al. p53-dependent G1 arrest and p53-independent apoptosis influence the radiobiologic response of glioblastoma. , 1996, International journal of radiation oncology, biology, physics.
[30] M. Lavin,et al. Radiosensitivity in ataxia-telangiectasia: anomalies in radiation-induced cell cycle delay. , 1994, International journal of radiation biology.
[31] P. Okunieff,et al. Intrinsic radiation sensitivity may not be the major determinant of the poor clinical outcome of glioblastoma multiforme. , 1992, International journal of radiation oncology, biology, physics.
[32] R. Painter,et al. Radioresistant DNA synthesis and human genetic diseases. , 1989, Human genetics.
[33] G. Steel,et al. Recovery from radiation damage in human squamous carcinoma of the cervix. , 1989, International journal of radiation biology.
[34] E. Harlow,et al. Antibodies: A Laboratory Manual , 1988 .